Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Net Change in Cash

Aquestive Therapeutics Inc Net Change in Cash Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Net Change in Cash from 2006 to 2018.
  • Aquestive Therapeutics Inc Net Change in Cash for the quarter ending September 09, 2018 was $53m a 115.12% increase of 61m year over year
  • Aquestive Therapeutics Inc Net Change in Cash for the last 12 months ending September 09, 2018 was $39m a 78.80% increase of 30m year over year
  • Aquestive Therapeutics Inc Annual Net Change in Cash for 2017 was $8m a 128.10% increase of 10m from 2016
  • Aquestive Therapeutics Inc Annual Net Change in Cash for 2016 was $-2m a 706.45% decrease of -16m from 2015
  • Aquestive Therapeutics Inc Annual Net Change in Cash for 2006 was $14m a 92.34% increase of 13m from 2005
Other Cash Flow Metrics:
  • Aquestive Therapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a 35.43% decrease of -4m year over year
  • Aquestive Therapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-6m a 59.44% decrease of -4m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Net Change in Cash Data

09/2018$53m
06/2018$-6m
03/2018$-1m
12/2017$-8m
09/2017$15m
06/2017$-7m
03/2017$8m
06/2007$-4m
03/2007$-4m
12/2006$5m

Annual AQST Net Change in Cash Data

2017$8m
2016$-2m
2006$14m
2005$1m
2004$0m